BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1779495)

  • 1. [Overexpression of c-myc, c-fos and Harvey ras oncogenes in renal cancers--analysis at the messenger RNA levels].
    Kunimi K; Uchibayashi T; Hisazumi H
    Nihon Hinyokika Gakkai Zasshi; 1991 Dec; 82(12):1924-9. PubMed ID: 1779495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of genetic alterations of c-myc, c-fos, and c-Ha-ras proto-oncogenes in colorectal tumors. Frequency and clinical significance.
    Nagai MA; Habr-Gama A; Oshima CT; Brentani MM
    Dis Colon Rectum; 1992 May; 35(5):444-51. PubMed ID: 1373678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of multiple oncogenes in human esophageal carcinomas.
    Wong FH; Hu CP; Chiu JH; Huang BS; Chang JP; Lin PJ; Chien KY; Chang C
    Cancer Invest; 1994; 12(2):121-31. PubMed ID: 8131089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of c-Ki-ras and c-fos in human pancreatic carcinomas.
    Wakita K; Ohyanagi H; Yamamoto K; Tokuhisa T; Saitoh Y
    Int J Pancreatol; 1992 Feb; 11(1):43-7. PubMed ID: 1583354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras.
    Volm M; Mattern J
    Anticancer Res; 1993; 13(6A):2021-5. PubMed ID: 8297109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression and amplification of c-myc in the Syrian hamster kidney during estrogen carcinogenesis: a probable critical role in neoplastic transformation.
    Li JJ; Hou X; Banerjee SK; Liao DZ; Maggouta F; Norris JS; Li SA
    Cancer Res; 1999 May; 59(10):2340-6. PubMed ID: 10344741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenes and growth factors in renal cell carcinoma.
    Peter S
    Urol Int; 1991; 47(4):199-202. PubMed ID: 1781103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Oncogene expression in malignant head and neck neoplasia].
    Sartoris A; Aluffi P; Montemagno A; Gerbaudo EV; Gariglio M; Cavallo GP
    G Batteriol Virol Immunol; 1991; 84(1-12):25-30. PubMed ID: 1844916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-myc, c-fos, and c-myb gene expression in human pituitary adenomas.
    Woloschak M; Roberts JL; Post K
    J Clin Endocrinol Metab; 1994 Jul; 79(1):253-7. PubMed ID: 8027238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of proto-oncogenes in normal and tumor tissues of human skin.
    Ogiso Y; Oikawa T; Kondo N; Kuzumaki N; Sugihara T; Ohura T
    J Invest Dermatol; 1988 Jun; 90(6):841-4. PubMed ID: 2897396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proto-oncogene expression in dermal naevi and melanomas.
    Peris K; Cerroni L; Chimenti S; Soyer HP; Kerl H; Höfler H
    Arch Dermatol Res; 1991; 283(8):500-5. PubMed ID: 1686168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MYC oncogene overexpression drives renal cell carcinoma in a mouse model through glutamine metabolism.
    Shroff EH; Eberlin LS; Dang VM; Gouw AM; Gabay M; Adam SJ; Bellovin DI; Tran PT; Philbrick WM; Garcia-Ocana A; Casey SC; Li Y; Dang CV; Zare RN; Felsher DW
    Proc Natl Acad Sci U S A; 2015 May; 112(21):6539-44. PubMed ID: 25964345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure and expression of c-myc and c-fos proto-oncogenes in thyroid carcinomas.
    Terrier P; Sheng ZM; Schlumberger M; Tubiana M; Caillou B; Travagli JP; Fragu P; Parmentier C; Riou G
    Br J Cancer; 1988 Jan; 57(1):43-7. PubMed ID: 3348948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A study on the transcriptional expression of oncogenes in human primary brain tumors].
    Sun N; Wen Y; Yan S; Sun Z; Zhou R; Liao W
    Hua Xi Yi Ke Da Xue Xue Bao; 1993 Jun; 24(2):135-8. PubMed ID: 8244289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inverse relationship of epidermal growth factor receptor and HER2/neu gene expression in human renal cell carcinoma.
    Weidner U; Peter S; Strohmeyer T; Hussnätter R; Ackermann R; Sies H
    Cancer Res; 1990 Aug; 50(15):4504-9. PubMed ID: 1973362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The expression of oncogenes in the development of human brain].
    Sun N; Sun Z
    Hua Xi Yi Ke Da Xue Xue Bao; 1992 Mar; 23(1):9-12. PubMed ID: 1398634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevation of protooncogene messenger RNAs in estrogen-induced kidney tumors in the hamster.
    Liehr JG; Chiappetta C; Roy D; Stancel GM
    Carcinogenesis; 1992 Apr; 13(4):601-4. PubMed ID: 1576713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of resistance factors (P-glycoprotein, glutathione S-transferase-pi, and topoisomerase II) and their interrelationship to proto-oncogene products in renal cell carcinomas.
    Volm M; Kästel M; Mattern J; Efferth T
    Cancer; 1993 Jun; 71(12):3981-7. PubMed ID: 8099529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of multiple oncogenes related to histological grade of astrocytic glioma.
    Orian JM; Vasilopoulos K; Yoshida S; Kaye AH; Chow CW; Gonzales MF
    Br J Cancer; 1992 Jul; 66(1):106-12. PubMed ID: 1322154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of c-myc and K-ras amplification in renal clear cell adenocarcinoma.
    Kozma L; Kiss I; Nagy A; Szakáll S; Ember I
    Cancer Lett; 1997 Jan; 111(1-2):127-31. PubMed ID: 9022137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.